Sveriges mest populära poddar

Microdosing GLP-1 and Cagrisema headlines

40 min•23 december 2024

Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fler avsnitt av Docs Who Lift

Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained

3 aug.•40 min

PCOS Renamed to PMOS? Here's Why and What Changes for You

7 juli•37 min

Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medicine

17 juni•57 min

Retatrutide Phase 3 Results: What the Data Actually Means

8 juni•45 min

GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely

25 maj•40 min

Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian

18 maj•32 min

Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo

5 maj•53 min

GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton

21 apr.•25 min

Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer

14 apr.•36 min

How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips

2 apr.•52 min

Docs Who Lift med Docs Who Lift finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.